Change in the number of votes relating to Biotie Therapies Corp.'s shares

        Print
| Source: Biotie Therapies
BIOTIE  THERAPIES CORP.                   Stock Exchange  Release            21
August 2014 at 10.05 am

Change in the number of votes relating to Biotie Therapies Corp.'s shares

Biotie Therapies Corp. ("Biotie" or the "Company") has conveyed Biotie shares
held as treasury shares, that were issued on 2 January 2014, pursuant to the
Stock Option Plan 2011 and the Equity Incentive Plan 2011 (the "Plans") as
follows:

  Shares   Cumulative shares Remaining shares to
  conveyed  conveyed since 2     be conveyed
              January 2014

  247,500      3,306,660           15,000


Under the Stock Option Plan 2011, the owners of the stock options may subscribe
for a maximum total of 7,401,000 new shares in the Company or existing shares
held by the Company. A total of 247,500 shares have been subscribed for during
the period 30 July 2014 and 20 August 2014 and 247,500 of the treasury shares
will be used for these share subscriptions. The subscription price of EUR 0.01
per share has been fully paid by the employee and the EUR 2,475 funds received
will be credited to the Company's reserve for non-restricted equity.

Based on the Equity Incentive Plan 2011 no shares have been conveyed during the
period 30 July 2014 and 20 August 2014.

The conveyed shares previously held as treasury shares have not carried any
voting rights. The conveyance does not affect the number of registered shares.
After the conveyances the changes are as follows:

 Increase in number Total amount of    Number of the     Total number
   of outstanding    voting rights  Company's share held of registered
       shares                           by the Group        shares

      247,500         450,681,015        5,351,383        456,032,398


Turku, 21 August 2014

Biotie Therapies Corp.
Timo Veromaa, President and CEO

For further information, please contact:
Virve Nurmi, Investor Relations Manager, Biotie Therapies Corp.
tel. +358 2 274 8900, e-mail: virve.nurmi@biotie.com
www.biotie.com

DISTRIBUTION:
NASDAQ OMX Helsinki Ltd
Main Media


[HUG#1850193]